For research use only. Not for therapeutic Use.
Oxaliplatin(Cat No.:M018541)is a platinum-based chemotherapy drug used primarily to treat colorectal cancer. It functions by forming crosslinks with DNA, inhibiting replication and transcription, and inducing apoptosis in rapidly dividing cancer cells. Oxaliplatin is often combined with other agents, such as fluorouracil, to enhance its efficacy in treatment regimens. Its unique mechanism of action, involving DNA adduct formation, gives it effectiveness against cancers resistant to other platinum drugs. Widely studied in oncology, Oxaliplatin is critical for understanding DNA damage responses, resistance mechanisms, and the development of targeted cancer therapies.
Catalog Number | M018541 |
CAS Number | 63121-00-6 |
Synonyms | Oxalato(trans-(-)-1,2-cyclohexanediamine)platinum(II);Oxaliplatin;61825-94-3 (Sp-4-2);Act 078;Nsc 271670;Oxalato(1,2-diaminocyclohexane)platinum(ii);Platinum (ii), (cyclohexane-1,2-diammine)oxalato-;Platinum, (1,2-cyclohexanediamine-kappan,kappan/’)( |
Molecular Formula | C6H14N2.C2O4.Pt |
Purity | ≥95% |
Target | Apoptosis |
Storage | Room Temperature |